Despite BLT-1 administration and Scarb1 CKO not preventing adaptive hypertrophy (Supplemental Figures 6C and 7B), they ultimately preserved cardiac function (Figures 4D and 5C), suggesting that blocking SCARB1 in ECs prevents the transition to heart failure. This evidence concerns the gene SCARB1 and heart failure.